TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins

被引:0
作者
Paus, Elisabeth [1 ]
Haugen, Mads Haugland [2 ]
Olsen, Kari Hauge [1 ]
Flatmark, Kjersti [2 ,3 ]
Maelandsmo, Gunhild Mari [2 ]
Nilsson, Olle [4 ]
Roijer, Eva [4 ]
Lundin, Maria [4 ]
Fermer, Christian [4 ]
Samsonova, Maria [5 ]
Lebedin, Yuri [5 ]
Stigbrand, Torgny [6 ]
机构
[1] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway
[2] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway
[3] Oslo Univ Hosp, Norwegian Radium Hosp, Clin Canc & Surg, Oslo, Norway
[4] Fujirebio Diagnost AB, Gothenburg, Sweden
[5] Xema Med Co Ltd, Moscow, Russia
[6] Umea Univ, Dept Immunol, Umea, Sweden
关键词
S100; proteins; Monoclonal antibodies; Antibody specificities; NEURON-SPECIFIC ENOLASE; S-100; PROTEIN; METHODOLOGICAL FEATURES; TUMOR-SUPPRESSOR; BRAIN-DAMAGE; SERUM S-100; ANNEXIN-VI; FAMILY; MELANOMA; MARKER;
D O I
10.1007/s13277-010-0073-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fourteen monoclonal antibodies with specificity against native or recombinant antigens within the S100 family were investigated with regard to immunoreactivity. The specificities of the antibodies were studied using ELISA tests, Western blotting epitope mapping using competitive assays, and QCM technology. The mimotopes of antibodies against S100A4 were determined by random peptide phage display libraries. Antibody specificity was also tested by IHC and pair combinations evaluated for construction of immunoradiometric assays for S100B. Out of the 14 antibodies included in this report eight demonstrated specificity to S100B, namely MAbs 4E3, 4D2, S23, S53, 6G1, S21, S36, and 8B10. This reactivity could be classified into four different epitope groups using competing studies. Several of these MAbs did display minor reactivity to other S100 proteins when they were presented in denatured form. Only one of the antibodies, MAb 3B10, displayed preferential reactivity to S100A1; however, it also showed partial cross-reactivity with S100A10 and S100A13. Three antibodies, MAbs 20.1, 22.3, and S195, were specific for recombinant S100A4 in solution. Western blot revealed that MAb 20.1 and 22.3 recognized linear epitopes of S100A4, while MAb S195 reacted with a conformational dependent epitope. Surprisingly, MAb 14B3 did not demonstrate any reactivity to the panel of antigens used in this study.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 31 条
  • [1] Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles
    Arcuri, C
    Giambanco, I
    Bianchi, R
    Donato, R
    [J]. NEUROSCIENCE, 2002, 109 (02) : 371 - 388
  • [2] Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma
    Bánfalvi, T
    Gilde, K
    Gergye, M
    Boldizsár, M
    Kremmer, T
    Ottó, S
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (02) : 164 - 169
  • [3] S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles
    Donato, R
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (07) : 637 - 668
  • [4] Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor
    Fernandez-Fernandez, MR
    Veprintsev, DB
    Fersht, AR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (13) : 4735 - 4740
  • [5] CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family
    Filipek, A
    Jastrzebska, B
    Nowotny, M
    Kuznicki, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) : 28848 - 28852
  • [6] Immunofluorometric assay for the metastasis-related protein S100A4: Release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum
    Flatmark, K
    Maelandsmo, GM
    Mikalsen, SO
    Nustad, K
    Varaas, T
    Rasmussen, H
    Meling, GI
    Fodstad, O
    Paus, E
    [J]. TUMOR BIOLOGY, 2004, 25 (1-2) : 31 - 40
  • [7] Annexin VI binds S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments
    Garbuglia, M
    Verzini, M
    Donato, R
    [J]. CELL CALCIUM, 1998, 24 (03) : 177 - 191
  • [8] Biological and methodological features of the measurement of S100B, a putative marker of brain injury
    Goncalves, Carlos-Alberto
    Leite, Marina Conch
    Nardin, Patricia
    [J]. CLINICAL BIOCHEMISTRY, 2008, 41 (10-11) : 755 - 763
  • [9] Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein - Functional consequences of their interaction
    Grigorian, M
    Andresen, S
    Tulchinsky, E
    Kriajevska, M
    Carlberg, C
    Kruse, C
    Cohn, M
    Ambartsumian, N
    Christensen, A
    Selivanova, G
    Lukanidin, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) : 22699 - 22708
  • [10] S100B protein detection in serum is a significant prognostic factor in metastatic melanoma
    Hauschild, A
    Engel, G
    Brenner, W
    Gläser, R
    Mönig, H
    Henze, E
    Christophers, E
    [J]. ONCOLOGY, 1999, 56 (04) : 338 - 344